Biosearch Technologies Names Marc Beal National Sales Manager
Ron Cook, President and CEO, comments, "We are extremely fortunate to have Marc assume a senior sales role in our rapidly expanding company. Marc's six year tenure as a scientist at Genentech in the 80's and his subsequent Sales and Marketing experience with Sepracor and E. Merck will enable Marc to quickly understand and fulfill the needs of our customers. We expect that Marc's technical capabilities and obsession with customer satisfaction will expand Biosearch's reputation for excellence in our core oligonucleotide-based markets. We further expect Marc to serve as a conduit through which our customer's future product needs can be directly conveyed to our new product R & D programs."
Biosearch Technologies is a leading developer of fluorescence quenching systems and a supplier of proprietary reagents, synthesis supports and specialty chemicals for genomics and proteomics R&D. Biosearch has developed and licenses the Black Hole Quencher ™ series of dark quenchers and is an innovator in the design and custom synthesis of advanced reporter/quencher systems for gene quantification, SNP discovery, detection & scoring, spectral genotyping and library screening.
Biosearch's proprietary synthesis robots allow the preparation of oligonucleotides more rapidly and more cost effectively than any commercially available system. Biosearch has also developed robot-based methodology, which addresses the downstream work- up, purification, analysis, and concentration normalization of oligonucleotides. These production capabilities position Biosearch at the threshold of leadership in the markets for high value oligonucleotide probes and oligonucleotide array components.
Biosearch's worldwide customer base includes major pharmaceutical companies, custom DNA synthesis companies, biotechnology companies and academic and government R&D laboratories.